Hypertension in pregnancy: diagnosis and management
KEYWORDS: women, hypertension, pre-eclampsia, pregnancy, treatment, birth, committee, recommendations, antihypertensive, amended, risk, blood, evidence, care, gestational

growth factor (PLGF)-based testing to help rule out pre-eclampsia between 20 weeks and 36 weeks and 6 days of pregnancy, if women with chronic hypertension are suspected of developing pre-eclampsia. (See the NICE diagnostics guidance on PLGF-based testing to help diagnose suspected preterm pre-eclampsia). [2019, amended 2023] For a short explanation of why the committee made the 2019 recommendations and how they might affect practice, see the rationale and impact section on treatment of chronic hypertension. Full details of the evidence and the committee's discussion are in evidence review A: interventions for chronic hypertension. Antenatal appointments 1.3.13 In women with chronic hypertension, schedule additional antenatal appointments based on the individual needs of the woman and her baby. This may include: • weekly appointments if hypertension is poorly controlled • appointments every 2 to 4 weeks if hypertension is well-controlled. [2010, amended 2019] Timing of birth 1.3.14 Do not offer planned early birth before 37 weeks to women with chronic hypertension whose blood pressure is lower than 160/110 mmHg, with or without antihypertensive treatment, unless there are other medical indications. [2010, amended 2019] 1.3.15 For women with chronic hypertension whose blood pressure is lower than 160/ 110 mmHg after 37 weeks,
